Redwood City, CA, United States of America

Robert M Parkhurst

This inventor holds 3 USPTO granted patents. Top assignees: Chemex Pharmaceuticals, Inc., Ito En, Ltd.. Active years: 1985-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert M Parkhurst. Retrieved from https://idiyas.com/inventor/robert-m-parkhurst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Redwood City, NV (US) (1990)
  • Redwood City, CA (US) (1985 - 1991)

Company Filing History:


Years Active: 1985-1991

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Inventor Robert M Parkhurst: Pioneering Innovations in Redwood City

Introduction: Robert M Parkhurst is a distinguished inventor based in Redwood City, CA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Robert M Parkhurst holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in innovation.

Career Highlights: With a career spanning over two decades, Robert M Parkhurst has worked with leading tech companies, research institutions, and universities, consistently pushing the boundaries of technological advancement.

Collaborations: Throughout his career, Robert M Parkhurst has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Robert M Parkhurst's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and engineers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…